StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Emmaus Life Sciences's revenue for the twelve months ending Jun 30, 2026 was $15.53M. For fiscal 2025 it was $12.45M, down 25.2% from the year before. Over ten years it grew 57.2% a year on average. The highest annual figure on record is $29.60M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$12.45M-25.2%
FY2024Dec 31, 2024$16.65M-43.7%
FY2023Dec 31, 2023$29.60M+60.9%
FY2022Dec 31, 2022$18.39M-10.8%
FY2021Dec 31, 2021$20.61M-11.0%
FY2020Dec 31, 2020$23.17M+1.8%
FY2019Dec 31, 2019$22.75M+17605.8%
FY2017Sep 30, 2017$128.50K+51.0%
FY2016Sep 30, 2016$85.10K-15.0%
FY2015Sep 30, 2015$100.10K-25.9%
FY2014Sep 30, 2014$135.10K+3.2%
FY2013Sep 30, 2013$130.90K-82.5%
FY2011Sep 30, 2011$745.90K+16.8%
FY2010Sep 30, 2010$638.50K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$6.32M+91.9%
Q1 FY2026CQ1 2026Mar 31, 2026$1.98M-63.8%
Q4 FY2025CQ4 2025Dec 31, 2025$3.85M-28.4%
Q3 FY2025CQ3 2025Sep 30, 2025$3.38M+34.8%
Q4 FY2024CQ4 2024Dec 31, 2024$3.29M-53.4%
Q3 FY2024CQ3 2024Sep 30, 2024$5.48M+9.2%
Q2 FY2024CQ2 2024Jun 30, 2024$5.38M-50.0%
Q1 FY2024CQ1 2024Mar 31, 2024$2.51M-62.9%
Q4 FY2023CQ4 2023Dec 31, 2023$7.07M+19.2%
Q3 FY2023CQ3 2023Sep 30, 2023$5.02M+1.6%
Q2 FY2023CQ2 2023Jun 30, 2023$10.76M+151.0%
Q1 FY2023CQ1 2023Mar 31, 2023$6.75M+108.8%
Q4 FY2022CQ4 2022Dec 31, 2022$5.93M+96.4%
Q3 FY2022CQ3 2022Sep 30, 2022$4.94M-14.3%
Q2 FY2022CQ2 2022Jun 30, 2022$4.29M-33.9%
Q1 FY2022CQ1 2022Mar 31, 2022$3.23M-39.4%
Q4 FY2021CQ4 2021Dec 31, 2021$3.02M-51.7%
Q3 FY2021CQ3 2021Sep 30, 2021$5.77M+2.9%
Q2 FY2021CQ2 2021Jun 30, 2021$6.49M+48.8%
Q1 FY2021CQ1 2021Mar 31, 2021$5.34M-23.3%
Q4 FY2020CQ4 2020Dec 31, 2020$6.25M-50.2%
Q3 FY2020CQ3 2020Sep 30, 2020$5.60M+2.0%
Q2 FY2020CQ2 2020Jun 30, 2020$4.36M+12723.5%
Q1 FY2020CQ1 2020Mar 31, 2020$6.95M+17112.9%
Q4 FY2019CQ4 2019Dec 31, 2019$12.55M+39248.0%
Q3 FY2019CQ3 2018Jun 30, 2019$5.49M+24643.2%
Q4 FY2017CQ3 2017Sep 30, 2017$34.00K+82.8%
Q3 FY2017CQ2 2017Jun 30, 2017$40.40K+91.5%
Q2 FY2017CQ1 2017Mar 31, 2017$31.90K+54.1%
Q1 FY2017CQ4 2016Dec 31, 2016$22.20K-10.1%
Q4 FY2016CQ3 2016Sep 30, 2016$18.60K-27.1%
Q3 FY2016CQ2 2016Jun 30, 2016$21.10K-31.9%
Q2 FY2016CQ1 2016Mar 31, 2016$20.70K-1.0%
Q1 FY2016CQ4 2015Dec 31, 2015$24.70K+8.8%
Q4 FY2015CQ3 2015Sep 30, 2015$25.50K–
Q3 FY2015CQ2 2015Jun 30, 2015$31.00K–
Q2 FY2015CQ1 2015Mar 31, 2015$20.90K–
Q1 FY2015CQ4 2014Dec 31, 2014$22.70K–

More Emmaus Life Sciences figures

See a number that looks wrong?